STEMPOINT CAPITAL LP - 31 Dec 2024 SCHEDULE 13G/A Report for Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares") (VTGN)

Filing Manager
STEMPOINT CAPITAL LP
Reporting Manager
StemPoint Capital LP
Security
Vistagen Therapeutics, Inc Common Stock, par value $0.001 per share ("Shares")
Symbol
VTGN
Shares outstanding
28,396,244 shares
Disclosed Ownership
2,328,492 shares
Ownership
8.2%
Form type
SCHEDULE 13G/A
Filing time
14 Feb 2025, 13:01:57 UTC
Date of event
31 Dec 2024
Next filing
17 Feb 2026
SEC
View on sec.gov

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
StemPoint Capital LP 8.2% 2,328,492 0 2,053,842 /s/ Sean C. Tan Sean C. Tan, Authorized Signatory
StemPoint Capital Management GP LLC 8.2% 2,328,492 0 2,053,842 /s/ Sean C. Tan Sean C. Tan, Authorized Signatory
Michelle Ross 8.2% 2,328,492 0 2,053,842 /s/ Michelle Ross Michelle Ross